Dr. Zhide Fang worked with a team of researchers from LSUHSC to determine a new noninvasive predictive #biomarker for necrotizing enterocolitis, a deadly intestinal disease found in newborns.
A diagnostic study of 136 premature infants found that a protein involved in managing harmful bacteria in the human intestine is a reliable biomarker for the noninvasive detection of necrotizing enterocolitis (NEC). Led by researchers and clinicians at LSU Health New Orleans School of Medicine, this is one of the largest prospective clinical studies in premature infants yet. The results of the study are published online in JAMA Network Open, available here.
